Carregando...
Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
Tenapanor (RDX5791, AZD1722), a first‐in‐class small molecule with minimal systemic availability, is an inhibitor of the sodium/hydrogen exchanger isoform 3. Tenapanor acts locally in the gut, where it reduces absorption of sodium and phosphate. It is being studied in patients with chronic kidney di...
Na minha lista:
| Publicado no: | Clin Pharmacol Drug Dev |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5599948/ https://ncbi.nlm.nih.gov/pubmed/27654985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.307 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|